chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1:43pm shortly after moderna covid sot and influenza vaccines, felt dizzy/heart reacing/shaky, said psyched herself out put head down/wanted to eat cereal bar-ate cereal bar and drank water/body armour drink she had with her sat up 1:46pm blood pressure/pulse: 1:50pm 103/80 69 (pt said high for usually 89/53) irregular heart beat symbol, says has PVCs 1:55pm 130/75 67 1:57pm 137/98 69 2:02pm 111/71 59 pulse, took prescribed alprazolam 1mg and ondansetron 4mg  2:04pm was cold applied blanket 2:05pm 124/71 64 2:06pm 127/81 77 (no irregular heart beat symbol) 2:07 pm ambulance arrived 2:09pm shaking 2:15pm paramedic said 2 PVCs in 6 minutes 2:20pm dizziness better after going to the restroom  paramedic said to patient had an anxiety attack from the shot doesn't think needs to go to the hospital in ambulance 2:23pm options- ride with Aunt to hospital or call pcp for further instructions-pt said she would go with her aunt and call her doctor
This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Dull headache) and VACCINATION SITE LYMPHADENOPATHY (Lymph node on the left under arm, the same where received shot) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. Concomitant products included APIXABAN (ELIQUIS) for an unknown indication. On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced HEADACHE (Dull headache). On an unknown date, the patient experienced VACCINATION SITE LYMPHADENOPATHY (Lymph node on the left under arm, the same where received shot). On 24-Feb-2021, HEADACHE (Dull headache) had resolved. At the time of the report, VACCINATION SITE LYMPHADENOPATHY (Lymph node on the left under arm, the same where received shot) outcome was unknown.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient is also on a heart medication she can't remember. No treatment medications provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 01-Mar-2021: Follow up received on 01MAR2021, Updated reporter details, Anatomical location of vaccine, vaccination facility details, concomitant medication Eliquis and additional event vaccination site lymphadenopathy.; Sender's Comments: Based on the current available information which shows a temporal association between the use of mRNA-1273 and the onset of the other events, a causal relationship cannot be excluded.  The reported events are consistent with the product known safety profile.
Patient had longstanding mild scleroderma. WIthin 2 days after second shot, the scleroderma "bloomed" affecting large swaths of skin with thickening and edema, and her fingers experienced contracting and rapid onset of fixed contractions. She blames vaccine totally for this sudden deterioration.
I NEED HELP!!!!!!! For over a year (April 2021), I have had CONSTANT phlegm/mucus that causes me to hack and spit every day, all day, worse at night, chases my husband out of our bedroom and basically makes my life HARD!!!! Every doctor I've seen has NO CLUE why all the tests/therapies/medications haven't even touched it. I am at my wit's end - suicidal at times. SOMEBODY PLEASE HEAR ME!!!!!  I only received ONE vaccine on the date I listed for item 4 - but I have received 4 total vaccines, all of which are listed in item 17. I was confused when the instructions asked me to enter all vaccines given on the date listed in item 4 - do you want just the one I got on that date or all the shots I've received thus far. Anyway, I did only get one vaccine on that day - EN6199/Pfizer   I have reason to believe my issue may be COVID related. The last time I gave blood, (always checks your blood for antibodies) showed I was highly reactive, meaning I either had it and had no 'normal' symptoms or was exposed and never knew it. I've written to the agency with my story because I read this article that sounds like what's going on with me.  I was asked to provide the lot # for my first vaccine as it was missing when I first submitted this form - that is NOT true - the lot # has always been Pfizer - EN6199. VAERSF Report Number: 874140
pt recv vax JUL97 & SEP97 & 1OCT97 & 5DEC97 serological testing revealed elevated transaminase levels of 62 & 57 respectively;
Pt fainted in office.  Monitored Pt B/P, pulse, SatO2.  Apple juice given.  Pt assessed by Dr.  Pt sent home.
2 weeks after the 3rd shot, on Dec 27 evening, I noticed my right eye was off and I had worn contacts that day, so I thought at first my eyes were dry. Next day, I couldn't see out of my right eye and I had significant blurred vision in right eye. I had ophthalmologist appointment already scheduled the 29th, and they said I wasn't seeing clearly out of right eye, and they said there was no infection or scarring. He put me on a dose of antiviral medications just in case it was a herpes flare and to come back in 2 weeks. It progressed quite rapidly and by the time I called ophthalmology on January 3 I said I couldn't see anything out of my right eye. I got in on Tuesday to see ophthalmology and I couldn't read the one big letter on the chart and the light wasn't getting it. I had a very insignificant reaction to light and my right eye pupil stayed big. That continued to get worse, and my ophthalmologist scheduled me for an MRI and a neurology appointment following the MRI. Another few days after, my vision continued to get worse and then starting around January 7 it started getting better. I had no other neuro symptoms such as motor problems, balance or vertigo symptoms, just diminished vision in right eye. I told ophthalmologist I had a CIS neuro episode 12 years ago in 2010 where I had a number of neuro symptoms such as double vision, vertigo, motor problems- and at time I didn't have health insurance and I had seen an ophthalmologist and they said I may have MS and I never had another episode and never sought care after that because I hadn't had any symptoms and thought it was a one and done thing. I'd also been taking increasingly good care of my health especially during the pandemic. I got an MRI and it showed no active lesions but the neurologist said that doesn't mean there wasn't active lesions it just means the MRI didn't see it There was scarring that indicated previous lesions related to 12 years ago. I did a spinal tap to compare breakdown proteins of brain myelin sheathing of nerves and apparently that was present in cerebral spinal fluid they determined I do have MS. I told neurologist it was 2 weeks today after I got vaccine and he said any significant jolt to immune system could trigger an episode. I am making an appointment to see MS specialist in a different city and going from there. My first doses were Moderna.
pt recv vax that morning & that evening pt devel fever of 104;fever occurred about 6-8hr p/vax;
No additional AEs were reported; The physician reported that a patient received improperly stored vaccine.  No additional AEs were reported, no further information provided.  Names of vaccines involved (including lot/exp) VARIVAX (u024221   8/4/2023) Temperature: -12.5C Time frame:; This spontaneous report was received from a physician regarding a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions, allergies or concomitant medications.   On 06-SEP-2022, the patient was vaccinated with an improperly stored vaccine of varicella virus vaccine live (Oka/Merck) (VARIVAX) for prophylaxis, lot # U024221 with expiration date on 04-AUG-2023 (strength, dose number, anatomical location and route of administration). The temperature storage was -12.5 C for a time frame of 1 hour, without a previous temperature excursion.  No additional adverse events were reported.
Fever; Muscle Soreness; booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 19Dec2021 13:00 (Batch/Lot number: unknown) at the age of 26 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: FLU taken for influenza, administration date 09Dec2021. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, administration time=15:30, Lot number: unknown, vaccine location=Left arm), administration date: 09Mar2021, when the patient was 25 years old, for Covid-19 Immunization; Bnt162b2 (DOSE 2, SINGLE, administration time=02:00, Lot number: unknown, vaccine location=Left arm), administration date: 30Mar2021, when the patient was 25 years old, for Covid-19 Immunization, reaction(s): "Chills", "Feeling hot", "Headache", "General body pain". The following information was reported: IMMUNISATION (non-serious) with onset 19Dec2021 13:00, outcome "unknown", described as "booster"; PYREXIA (non-serious) with onset 20Dec2021 01:00, outcome "recovering", described as "Fever"; MYALGIA (non-serious) with onset 20Dec2021 01:00, outcome "recovering", described as "Muscle Soreness". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, myalgia. Additional information: No other medications were taken in two weeks. The patient did not have COVID prior vaccination. The patient was not tested for COVID tested post vaccination. The patient did not have any known allergies or other medical history.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PT complains of itching in anterior face. PT also complained of shortness of breath and difficulty swallowing. PT further complained of hot flushed skin and posterior center chest pain that radiated into her anterior chest. PT had no notable rash or hives to be present. PT treated with IV Benadryl 50mg and solumedrol which decreased pt symptoms. Pt transported to ER for further evaluation by ambulance.
I had been have a pain in my arm ; took it on my left arm, it has been sore; I have been getting some like bit itchy like throbbing pain in arm ; I am just continuing to get these throbbing pain in my arm like from the top of the way to my head; I have been getting some like bit itchy like throbbing pain in arm; It wakes me up throughout ; sometimes it's been like wake up to sleep, it's just totally numb; It wakes me up throughout ; sometimes it's been like wake up to sleep; This is a spontaneous report from a contactable consumer (patient) reported for self. A patient of an unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date (age at vaccination was unknown) as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date (age at vaccination was unknown) as dose 1, single for COVID-19 immunization and after the first dose, the patient's left arm had been sore and the patient had been getting some like bit itchy like throbbing pain in arm. The patient had taken both of the Pfizer shot and the second one to that to tomorrow would be two weeks. On an unspecified date, after the second dose, the patient had a pain in arm, the patient took the vaccine in left arm and it had been sore. The patient had been getting some like bit itchy like throbbing pain in arm, the patient was just continuing to get this throbbing pain in arm like from the top of the way to head. The patient wakes up, it wakes the patient up throughout. Sometimes during the day it was not as bad and like it just sometimes, it was like wake up to sleep, it was just totally numb. The patient just wanted to know if there was anything to get that checked out and if the patient needed to be concerned about that. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Patient presented with redness and swelling measuring 1.5 inch in width and length. The site was in the back of the (L) arm where Varicella was given.
When I got my shot my heart rate went really high - 147. I figured it was anxiety but just read an article that said it could have been an allergic reaction (cardiovascular) so now I don't know if I should have the 2nd shot. My heart rate was high (over 100) for 3 hours and then higher than normal into the next day.
JYNNEOS EUA Received a patient complaint that the Jynneos vaccine was supposed to be administered intradermally but was administered subcutaneously because there was no visible "wheal" and concerned she would not receive the full protection since the dose administered was 0.1mL. Per provider the vaccine is recommended to be repeated via intradermal route immediately.
1-14-15 Pt was given ROTARIX diluent and KINRIX mixed together orally - the KINRIX was mixed instead of the ROTARIX - we called GlaxoSmithKline and CDC - mom aware and pt has received the ROTARIX today 1-16-15 the nurse prepared the MD administered.
pt recv vax 5SEP96 & 6SEP96 had gen tonic-clonic sz @ 4AM;fever
Shingles; This is a spontaneous report from a contactable consumer (patient himself). A 46-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiration date was not reported) via an unspecified route of administration, administered in Arm Left on 14Apr2021 12:00 (at age of 46-years-old) as DOSE 2, SINGLE for COVID-19 immunization. Patient's medical history was not reported. Patient had not known allergies. Concomitant medication included cetirizine hydrochloride (ZYRTEC ALLERGY) taken for an unspecified indication. Patient had previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiration date was not reported) via an unspecified route of administration, administered in Arm Left on 24Mar2021 12:00 (at age of 46-years-old) as DOSE 1, SINGLE for COVID-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced shingles on 16Apr2021 12:00. Patient did not receive any treatment for adverse event. Patient did COVID test post vaccination (not specified). The outcome of event was not recovered.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Injection was given very low in the shoulder, and at the time of injection a nerve type pain was felt all the way up my arm and into my neck. The next two days I had an exaggerated immune response with fever, chills, nausea and a very sore arm. The third day I woke up that morning and was totally unable to move the arm that I received the vaccine in. The whole arm felt like it had a severe muscle cramp and sharp pain. I used my other arm to move this arm and stretch it out a little and was able to regain limited range of motion.  18 days later I am still experiencing severe pain and very limited range of motion in the vaccine shoulder.  I went to my PCP on Nov 2nd and she confirmed that the pain  was inflammation and  injury from the flu shot. She gave me a steroid shot and told me to follow up if it didn?t get better in a week or two.  The steroid shot provided no relief and the pain and limited range of motion has worsened, not improved since then.
watery bag under his arm; painful lymph nodes; swollen lymph nodes; his left arm has swollen; painful lymph node around the injection site; painful lymph node around the injection site; booster; received the first two doses of the Moderna Covid-19 vaccine and Pfizer Covid-19 booster dose last Monday; received the first two doses of the Moderna Covid-19 vaccine and Pfizer Covid-19 booster dose last Monday; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non- health care professional) from medical information team for a Pfizer sponsored program. The reporter is the patient. Other Case identifier(s): PFIZER INC-202101751445.  A 56-years-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 06Dec2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: MODERNA COVID-19 vaccine (first dose of the MODERNA COVID-19 vaccine), for COVID-19 immunization; MODERNA COVID-19 vaccine (2nd dose of the MODERNA COVID-19 vaccine), for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 06Dec2021, outcome "unknown", described as "booster"; OFF LABEL USE (non-serious), INTERCHANGE OF VACCINE PRODUCTS (non-serious) all with onset 06Dec2021, outcome "unknown" and all described as "received the first two doses of the MODERNA COVID-19 vaccine and Pfizer Covid-19 booster dose last Monday"; LYMPH NODE PAIN (non-serious) with onset 08Dec2021, outcome "unknown", described as "painful lymph nodes"; LYMPHADENOPATHY (non-serious) with onset 08Dec2021, outcome "unknown", described as "swollen lymph nodes"; CYST (non-serious), outcome "unknown", described as "watery bag under his arm"; PERIPHERAL SWELLING (non-serious) with onset 07Dec2021, outcome "unknown", described as "his left arm has swollen"; VACCINATION SITE LYMPHADENOPATHY (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 07Dec2021, outcome "unknown" and all described as "painful lymph node around the injection site".  Additional information: Caller received the first two doses of the MODERNA COVID-19 vaccine and PFIZER COVID-19 booster dose last Monday. He stated that his left arm had swollen, painful lymph node around the injection site. He mentioned that it was swollen yesterday and he got it on Monday. This Wednesday would be the second day, he said that he woke up with a lot of swelling under the arm, lymph nodes under the arm, it was just somewhat painful. He mentioned that he looked it and it sounds like it was normal. He wants to know if this was normal or not.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Medical assistant administered MMRV and varicella to a 17 month old patient. Parents contacted by Provider to explain risks and monitor child.
Information has been received from a licensed visiting nurse concerning a 23 year old female who was vaccinated with two doses of varicella vaccine in January 1999 and February 1999. In September 1999, a serum varicella virus antibody test was "weakly positive." In approximately April 2001, the serum varicella virus antibody test revealed "no seroconversion." No further info is expected.
Urinary tract infection; Allergy (anaphylaxis) to levofloxacin; Hives; Difficult breathing; Felt awful; Sluggish; Light-headed; A spontaneous report was received from a consumer concerning herself, a 75-year-old female patient, who received 2 doses of Moderna's COVID-19 vaccine (mRNA-1273) and experienced allergy (anaphylaxis) to levofloxacin (anaphylactic reaction), hives (urticaria), difficult breathing (dyspnoea), felt awful (feeling abnormal), sluggish, and light-headed (dizziness).  The patient's medical history, as provided by the reporter included urinary tract infection (UTI).Medications included levofloxacin and nitrofurantoin to treat urinary tract infection.  On 19 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch Number: 010M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 16 Feb 2021, the patient received their second of two planned doses of mRNA-1273 (Batch Number: 013L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 05 Mar 2021, the patient took levofloxacin 500mg to treat urinary tract infection (UTI). Soon thereafter patient had a severe allergic reaction to levofloxacin.   Treatment included Emergency Room drug-induced anaphylaxis treatment.Later Patient took nitrofurantoin for 5 days for the UTI and developed events sluggish, and light-headed hives,felt awful and difficult breathing.  Action taken with mRNA-1273 in response to the events was not applicable.   The outcome of the event, allergy (anaphylaxis) to levofloxacin was resolved on 05 Mar 2021. The outcome of the event, hives, difficult breathing, felt awful, sluggish, and light-headed, were unknown.; Reporter's Comments: This case concerns a 75 Y/O F who had NS unexpected urinary tract infection and serious unexpected anaphylactic reaction with NS unexpected urticaria, dyspnea, dizziness, feeling abnormal, sluggish.  Anaphylaxis on Day 18 after first dose mRNA-1273 was considered possibly related to levofloxacin for UTI. Anaphylaxis resolved. Based on current available information and temporal association between use of the product and the start date of the event, a causal relationship cannot be excluded.
Redness, swelling, itching RUE 7 days post vaccine. Bilateral legs itching day 9.
This spontaneous report as received from a nurse regarding herself as a female patient of unknown age. Information on medical history, past drugs, concurrent conditions and concomitant medications were not provided. On 06-FEB-2018, the patient while administering the vaccine, M-M-R II, (lot # N013281, Exp date: 28-APR-2019), (Dose, route, frequency were not provided) for prophylaxis, some of the liquid came out and splashed her in the face. No adverse reaction was reported and no further clarifying information was provided. It was reported that product quality complaint (PQC) was not present.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. The patient's pertinent medical history and drug allergies were not reported. In 2012 the patient was vaccinated with the first and second dose of GARDASIL (lot#, expiration date, dose, strength and route unknown). On 14-AUG-2015 the patient came to the physician's office to receive the third dose of GARDASIL (lot#, expiration date, dose, strength and route unknown). No adverse effects reported. Additional information has been requested.
severe h/a, hypertensive episode, palpitations 10 days rx beta blocker;